结节病肺移植的结局与预后因素
该研究回顾性分析了2006至2019年间欧洲16个中心112例接受肺或心肺移植的结节病患者,中位年龄52岁,男性占64%。移植后1、3、5年生存率分别为86%、76%、69%,31%发生慢性肺移植物功能障碍。年龄较大和广泛肺纤维化与死亡率增加相关,而移植后生存与其他肺移植适应症相似。
要点
- 结节病肺移植后1、3、5年生存率分别为86%、76%、69%。
- 年龄较大和术前广泛肺纤维化与死亡率增加相关。
- 31%的患者在随访期间发生慢性肺移植物功能障碍。
核心结论
- 结节病肺移植后生存率与其他肺移植适应症相似。
- 年龄较大和术前广泛肺纤维化是生存不良的主要因素。
研究设计与样本
- 回顾性研究,纳入112例符合国际诊断标准并接受肺或心肺移植的结节病患者。
- 移植时间2006至2019年,来自16个欧洲中心。
主要发现
- 移植后1年、3年、5年生存率分别为86%、76%、69%。
- 随访中位46个月期间,31%的患者发生慢性肺移植物功能障碍。
- 年龄和广泛肺纤维化与死亡率增加相关。
- 外周为主的肺纤维化与短期并发症相关。
关键数值与推荐
- 肺表型分布:仅广泛纤维化17%,气流阻塞16%,严重肺动脉高压(sPH)和气流阻塞17%,sPH、气流阻塞和纤维化14%,sPH和纤维化11%,气流阻塞和纤维化9%,仅sPH 5%,不符合以上标准11%。
临床怎么用
- 评估结节病患者肺移植适应症时,应考虑年龄和术前肺纤维化范围以预测预后。
- 移植后需监测慢性肺移植物功能障碍的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: In patients with sarcoidosis, past and ongoing immunosuppressive regimens, recurrent disease in the transplant and extrapulmonary involvement may affect outcomes of lung transplantation. We asked whether sarcoidosis lung phenotypes can be differentiated and, if so, how they relate to outcomes in patients with pulmonary sarcoidosis treated by lung transplantation. PATIENTS AND METHODS: We retrospectively reviewed data from 112 patients who met international diagnostic criteria for sarcoidosis and underwent lung or heart-lung transplantation between 2006 and 2019 at 16 European centres. RESULTS: Patient survival was the main outcome measure. At transplantation, median (interaquartile range (IQR)) age was 52 (46-59) years; 71 (64%) were male. Lung phenotypes were individualised as follows: 1) extended fibrosis only; 2) airflow obstruction; 3) severe pulmonary hypertension (sPH) and airflow obstruction; 4) sPH, airflow obstruction and fibrosis; 5) sPH and fibrosis; 6) airflow obstruction and fibrosis; 7) sPH; and 8) none of these criteria, in 17%, 16%, 17%, 14%, 11%, 9%, 5% and 11% of patients, respectively. Post-transplant survival rates after 1, 3, and 5 years were 86%, 76% and 69%, respectively. During follow-up (median (IQR) 46 (16-89) months), 31% of patients developed chronic lung allograft dysfunction. Age and extended lung fibrosis were associated with increased mortality. Pulmonary fibrosis predominating peripherally was associated with short-term complications. ANSWER TO THE STUDY QUESTION: Post-transplant survival in patients with pulmonary sarcoidosis was similar to that in patients with other indications for lung transplantation. The main factors associated with worse survival were older age and extensive pre-operative lung fibrosis.
引用
- Le Pavec J, Valeyre D, Gazengel P, et al. Lung transplantation for sarcoidosis: outcome and prognostic factors. Eur Respir J. 2021. PMID: 33479107. doi:10.1183/13993003.03358-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。